Along this line, recent evidences suggested that inhibition of the MAPK pathway in melanoma cells may result in the block of the production of tumor-derived immunosuppressive or proangiogenetic factors including IL-6, IL-10 and VEGF that are essential for cancer immune evasion and growth [44]. This evidence concerns the gene IL10 and cancer.